Drug Promotion During Pandemic: Website Links To Telemedicine Prescribers Require Caution

 
• By Brenda Sandburg

Growing trend of linking product websites to telehealth services raises regulatory concerns. Virtual interactions with healthcare providers might necessitate new FDA guidance, lawyers note at FDLI annual meeting.

Telemedicine
Drug site links to telemedicine providers raise promotion compliance concerns • Source: Alamy

More from Marketing & Advertising

More from Compliance